EcoR1 Capital, LLC CRSP Holdings History

Number of Shares
1.39 Mil
Current Holdings Value*
$47.28 Mil
% of Portfolio
2.8%
Total Estimate Gain
$-32.43 Mil
% of Total Estimate Gain
-11.65%

EcoR1 Capital, LLC's CRISPR Therapeutics AG Holding Summary

As of 2025-03-31, EcoR1 Capital, LLC held 1.39 Mil shares of CRISPR Therapeutics AG(CRSP), totaling $47.28 Mil. This investment constitutes 2.8% of their stock portfolio, and EcoR1 Capital, LLC now holds 1.61% of the outstanding CRISPR Therapeutics AG(CRSP) stock.

The initial trade took place in 2018Q3. And since then EcoR1 Capital, LLC has made 5 purchases of CRSP, at an average price of $59.66, for a total of 4.67 Mil shares. In addition, there have been 5 sales at an average price of $50.98 for 3.28 Mil shares. Based on historical transaction data and CRSP's current price of $56.80, EcoR1 Capital, LLC's estimated gain on his CRSP holdings is $-32.43 Mil, reflecting a -11.65% gain to date.

EcoR1 Capital, LLC CRSP ($56.80) Holding Chart

EcoR1 Capital, LLC CRSP ($56.80) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1